• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙BRCA1和BRCA2基因突变复发频率较低。

Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain.

作者信息

Llort Gemma, Muñoz Carmen Yagüe, Tuser Mercè Peris, Guillermo Ignacio Blanco, Lluch José Ramón Germà, Bale Allen E, Franco Mayra Alvarez

机构信息

Unidad de Consejo Genético. Servicio de Prevención y Control del Cáncer, Instituto Catalonian National Cancer Institute, Barcelona, Spain.

出版信息

Hum Mutat. 2002 Mar;19(3):307. doi: 10.1002/humu.9014.

DOI:10.1002/humu.9014
PMID:11857748
Abstract

BRCA1 and BRCA2 mutations underlie a substantial proportion of all hereditary breast cancer. The mutational spectrum in these genes is very broad, with hundreds of different BRCA mutations reported worldwide. However, high frequency founder mutations make up a substantial fraction of all mutations in some ethnic groups. We directly sequenced BRCA1 and BRCA2 in 35 Spanish breast/ovarian cancer families and found 13 mutations of which 3 had been reported previously in Spain. The ten novel mutations are: IVS5+1 G>A, 1491delA, Leu1086Ter, and Gln895Ter in BRCA1; Glu49Ter, 5373delGTAT, 5947delCTCT, 6672delTA, 8281insA, and Pro3039Leu (which also involves a splice site) in BRCA2. Our data, in combination with previous reports, indicate that 14 mutations have been seen recurrently in Spanish families. Analyzing these 14 mutations in 42 previously untested breast/ovarian cancer families revealed only two families testing positive, one for BRCA1 185delAG and one for BRCA2 9254delATCAT. While several mutations have been found recurrently in Spain, none appear to be high frequency founder mutations based on studies of breast and ovarian cancer families.

摘要

BRCA1和BRCA2基因的突变是所有遗传性乳腺癌的一大部分病因。这些基因的突变谱非常广泛,全球已报道了数百种不同的BRCA突变。然而,高频始祖突变在某些种族群体的所有突变中占很大比例。我们对35个西班牙乳腺癌/卵巢癌家系中的BRCA1和BRCA2进行了直接测序,发现了13种突变,其中3种此前已在西班牙报道过。这10种新突变分别是:BRCA1基因中的IVS5+1 G>A、1491delA、Leu1086Ter和Gln895Ter;BRCA2基因中的Glu49Ter、5373delGTAT、5947delCTCT、6672delTA、8281insA和Pro3039Leu(该突变也涉及一个剪接位点)。我们的数据与之前的报告相结合,表明在西班牙家系中已反复发现14种突变。对42个此前未检测的乳腺癌/卵巢癌家系中的这14种突变进行分析,仅发现两个家系检测呈阳性,一个家系携带BRCA1基因的185delAG突变,另一个家系携带BRCA2基因的9254delATCAT突变。虽然在西班牙已反复发现几种突变,但基于对乳腺癌和卵巢癌家系的研究,似乎没有一种是高频始祖突变。

相似文献

1
Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain.西班牙BRCA1和BRCA2基因突变复发频率较低。
Hum Mutat. 2002 Mar;19(3):307. doi: 10.1002/humu.9014.
2
Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.西班牙乳腺癌/卵巢癌患者中BRCA1和BRCA2基因分析:西班牙特有的高比例突变及奠基者效应证据
Hum Mutat. 2003 Oct;22(4):301-12. doi: 10.1002/humu.10260.
3
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.54个智利乳腺癌/卵巢癌家族中BRCA1和BRCA2突变的发生率及基因型-表型相关性
Breast Cancer Res Treat. 2006 Jan;95(1):81-7. doi: 10.1007/s10549-005-9047-1. Epub 2005 Oct 27.
4
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.波兰北部乳腺癌和卵巢癌家族中BRCA1和BRCA2基因的点突变及大片段重排
Oncol Rep. 2008 Jan;19(1):263-8.
5
BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin.BRCA1 5272-1G>A 和 BRCA2 5374delTATG 是西班牙裔乳腺癌/卵巢癌家族遗传咨询中具有高度相关性的热点突变。
Clin Genet. 2010 Jan;77(1):60-9. doi: 10.1111/j.1399-0004.2009.01272.x. Epub 2009 Nov 2.
6
Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.土耳其乳腺癌/卵巢癌患者BRCA1和BRCA2基因的种系突变
Hum Mutat. 2003 Apr;21(4):444-5. doi: 10.1002/humu.9119.
7
A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.德系犹太裔乳腺癌-卵巢癌家族中非始祖BRCA1突变的低发生率。
Hum Mutat. 2002 Nov;20(5):352-7. doi: 10.1002/humu.10123.
8
Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families.对32个西班牙乳腺癌和/或卵巢癌家族的BRCA1和BRCA2基因进行分子分析。
Br J Cancer. 2000 Apr;82(7):1266-70. doi: 10.1054/bjoc.1999.1089.
9
Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.来自德国北部乳腺癌和/或卵巢癌家族中的十种新型BRCA1和BRCA2突变
Hum Mutat. 2000 Dec;16(6):529-30. doi: 10.1002/1098-1004(200012)16:6<529::AID-HUMU14>3.0.CO;2-K.
10
High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.来自哥伦比亚的西班牙裔乳腺癌/卵巢癌家族中BRCA1/2始祖突变的比例很高。
Breast Cancer Res Treat. 2007 Jun;103(2):225-32. doi: 10.1007/s10549-006-9370-1. Epub 2006 Nov 2.

引用本文的文献

1
Using species richness calculations to model the global profile of unsampled pathogenic variants: Examples from BRCA1 and BRCA2.使用物种丰富度计算来模拟全球未采样的致病性变异体分布模式:BRCA1 和 BRCA2 的实例。
PLoS One. 2023 Feb 8;18(2):e0278010. doi: 10.1371/journal.pone.0278010. eCollection 2023.
2
A Multi-Center Study of and Germline Mutations in Mexican-Mestizo Breast Cancer Families Reveals Mutations Unreported in Latin American Population.一项关于墨西哥梅斯蒂索乳腺癌家族中[具体基因]和种系突变的多中心研究揭示了拉丁美洲人群中未报告的突变。 (注:原文中“and”前后的具体基因缺失)
Cancers (Basel). 2019 Aug 26;11(9):1246. doi: 10.3390/cancers11091246.
3
Non- Variants Detected in a High-Risk Chilean Cohort With a History of Breast and/or Ovarian Cancer.
在有乳腺癌和/或卵巢癌病史的智利高危队列中未检测到变异体。
J Glob Oncol. 2019 May;5:1-14. doi: 10.1200/JGO.18.00163.
4
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.西班牙东南部穆尔西亚地区遗传性乳腺癌和卵巢癌家族中BRCA1/BRCA2基因变异的分子特征及临床解读:BRCA携带者和非携带者的临床病理特征
Fam Cancer. 2017 Oct;16(4):477-489. doi: 10.1007/s10689-017-9985-x.
5
Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort.在挪威乳腺癌或卵巢癌队列中发现的BRCA1和BRCA2变异的特征分析。
Fam Cancer. 2017 Jan;16(1):1-16. doi: 10.1007/s10689-016-9916-2.
6
BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.家族性乳腺癌和卵巢癌综合征男性患者中的BRCA1和BRCA2突变。一项西班牙多中心研究的结果。
Fam Cancer. 2015 Dec;14(4):505-13. doi: 10.1007/s10689-015-9814-z.
7
Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence.在西班牙东部瓦伦西亚社区癌症遗传咨询计划中发现的早发性和家族性乳腺癌和卵巢癌中新型和反复出现的 BRCA1/BRCA2 突变。家族表型与突变流行率的关系。
Fam Cancer. 2013 Dec;12(4):767-77. doi: 10.1007/s10689-013-9622-2.
8
Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.在美国西南部进行遗传癌症风险评估的西班牙裔人群中 BRCA 突变的流行率和类型:来自临床癌症遗传学社区研究网络的报告。
J Clin Oncol. 2013 Jan 10;31(2):210-6. doi: 10.1200/JCO.2011.41.0027. Epub 2012 Dec 10.
9
Family history and breast cancer hormone receptor status in a Spanish cohort.家族史与西班牙队列乳腺癌激素受体状态
PLoS One. 2012;7(1):e29459. doi: 10.1371/journal.pone.0029459. Epub 2012 Jan 6.
10
Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome.BRCA1始祖突变c.5266dup在巴西遗传性乳腺癌和卵巢癌综合征高危个体中的患病率。
Hered Cancer Clin Pract. 2011 Dec 20;9(1):12. doi: 10.1186/1897-4287-9-12.